domingo, 22 de octubre de 2023

Stimulation of TREM2 with agonistic antibodies—an emerging therapeutic option for Alzheimer's disease Schlepckow et al.

https://www.thelancet.com/journals/laneur/home

No hay comentarios:

Publicar un comentario